Biotech notches 31 IPOs already this year, with 4 more joining queue

The sector’s IPO tally has surpassed each of the past four years, with four October debuts adding momentum—but activity still remains well below the COVID-19 boom that saw nearly 100 public debuts in 2021.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top